THE Health Department has advised of an extension for the mandatory inclusion of the Compounder ID with eligible claims under the Efficient Funding for Chemotherapy (EFC) scheme.
Previously it was intended that the compounder ID would become compulsory for claims lodged effective from 01 Apr 2017.
However according to an update on Fri, "a number of approved suppliers have indicated that the necessary amendments to their dispensing software may not be ready in time to facilitate this".
The department says it will now provide three months' notice before the field becomes mandatory.
Until then claims submitted without the compounder ID will continue to generate a warning but will not be rejected.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Mar 17
